July 2024

A listing of the individual articles included in the Jurisdiction F Medicare A News bulletin dated July 2024 is provided. Each article title functions as a hyperlink to a specific article.

paginationType regular
Articles Source
Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268) (A57843) - R3 - Effective April 4, 2024
Billing and Coding: MolDX: SMPD1 Genetic Testing (A55631) Retirement - Effective May 21, 2024
Billing and Coding: MolDX: STAT3 Gene Testing (A55481) Retirement - Effective April 24, 2024
Billing and Coding: MolDX: TERC Gene Tests (A55616) Retirement - Effective May 1, 2024
Billing and Coding: MolDX: TP53 Gene Tests (A55487) Retirement - Effective May 1, 2024
Billing and Coding: MolDX: VEGFR2 Tests (A55469) Retirement - Effective April 23, 2024
Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) (A56573) - R5 - Effective January 10, 2021
Billing and Coding: Peripheral Nerve Stimulation (A55531) - R7 - Effective March 1, 2024
Billing and Coding: Sacroiliac Joint Injections and Procedures (A59244) - R5 - Effective June 1, 2024
Billing and Coding: Serum Magnesium (A57198) - R8 - Effective October 1, 2023
Billing and Coding: Trigger Point Injections (A57702) - R5 - Effective April 1, 2024
Billing and Coding: Wound and Ulcer Care (A58567) - R6 - Effective April 1, 2024
Billing the Subsequent Inpatient Care 99232 Correctly - Appeals Newsletter Part 9
Change Healthcare Security Incident - Resolved 04/24/24 Alert
Clinical Laboratory Fee Schedule & Laboratory Services Reasonable Charge Payment: Quarterly Update CR13613
Comprehensive Error Rate Testing: Reporting Year 2024 Progress Report Letters
DMEPOS Fee Schedule: April 2024 Quarterly Update - Revised CR13574
DMEPOS Fee Schedule: July 2024 Quarterly Update CR13658
ESRD Prospective Payment System: Quarterly Update CR13608
HCPCS Codes Used for SNF CB Enforcement: October 2024 Quarterly Update CR13661
Hospital Outpatient Prospective Payment System: April 2024 Update CR13568
ICD-10 & Other Coding Revisions to National Coverage Determinations: October 2024 Update CR13596
July 2024 I/OCE Specifications Version 25.2 CR13626
Local Coverage Determinations (LCDs) Finalized - Effective July 28, 2024
Local Coverage Determinations (LCDs) Finalized - Effective July 7, 2024
Medicare Benefit Policy Manual Update: DMEPOS BCD CR13651
Medicare Claims Processing Manual Update: IRF CR13587
MLN Connects - April 11, 2024
MLN Connects - April 18, 2024
MLN Connects - April 25, 2024
MLN Connects - April 4, 2024
MLN Connects - June 13, 2024
MLN Connects - June 20, 2024
MLN Connects - June 27, 2024
MLN Connects - June 6, 2024
MLN Connects - May 16, 2024
MLN Connects - May 2, 2024
MLN Connects - May 23, 2024
MLN Connects - May 30, 2024
MLN Connects - May 9, 2024
MolDX: Blood Product Molecular Antigen Typing (L38333) - R4 - Effective May 23, 2024
MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic services (A59744) - Effective May 2, 2024
MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic Services (A59744) - R1 - Effective May 23, 2024
MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (L38974) - R1 - April 18, 2024
MolDX: Melanoma Risk Stratification Molecular Testing (L37748) - R6 - Effective June 20, 2024
MolDX: Pigmented Lesion Assay (L38153) - R1 - Effective June 20, 2024
MolDX: Repeat Germline Testing (L38353) - R2 - Effective April 25, 2024
Multi-Jurisdictional CAC Meeting Announcement - MolDX: Biomarker Risk Stratification Testing in DCIS - July 15, 2024, 2 p.m. to 4 p.m. ET
National Coverage Determination 20.7: Percutaneous Transluminal Angioplasty CR13512
National Coverage Determination 200.3: Monoclonal Antibodies for the Treatment of Alzheimer’s Disease CR13598
— 50 Items per Page
Showing 51 - 100 of 116 results.